China Charges Former Traditional Medicine Head Over Drug Approval Graft
Listen to the full version
China’s sweeping anti-corruption campaign in the healthcare sector has ensnared the former head of the country’s traditional medicine regulatory body, who has been indicted on bribery charges.
The Supreme People’s Procuratorate announced Friday that the National Commission of Supervision has concluded its investigation into Yu Wenming, former director of the National Administration of Traditional Chinese Medicine. Yu has been formally arrested and the case has been transferred to prosecutors in the northern municipality of Tianjin, who have filed an indictment with the Tianjin No. 1 Intermediate People’s Court.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to Save an extra $50. Introductory offer for new readers. Subscribe now.
- RELATED
- DIGEST HUB
Digest Hub
Back
- Yu Wenming, ex-director of National Administration of Traditional Chinese Medicine, indicted for bribery as deputy director.
- Allegations include huge bribes for drug approvals, aiding relatives; investigated June 2025, highest TCM official prosecuted.
- 18th centrally managed official prosecuted in 2026 amid healthcare anti-corruption campaign.
- PODCAST
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新